Reply to "Weekly paclitaxel in elderly breast cancer patients", by C. Smorenburg et al.

被引：2
作者：
Del Mastro, L [1 ]
Perrone, F
机构：
[1] Natl Inst Canc Res, Dept Med Oncol, Genoa, Italy
[2] NCI, Clin Trials Unit, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷 / 12期
关键词：
breast cancer; prophylactic endocrine treatment; chemoprevention;
D O I：
10.1093/annonc/mdi387
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1979 / U1
页数：2
相关论文
共 5 条
[1]   Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer:: French adjuvant study group [J].
Bonneterre, J ;
Roché, H ;
Kerbrat, P ;
Fumoleau, P ;
Goudier, MJ ;
Fargeot, P ;
Montcuquet, P ;
Clavère, P ;
Barats, JC ;
Monnier, A ;
Veyret, C ;
Datchary, J ;
Van Praagh, I ;
Chapelle-Marcillac, I .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) :3070-3079
[2]   Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer) [J].
Del Mastro, L ;
Perrone, F ;
Repetto, L ;
Manzione, L ;
Zagonel, V ;
Fratino, L ;
Marenco, D ;
Venturini, M ;
Maggi, E ;
Bighin, C ;
Catzeddu, T ;
Venturino, A ;
Rosso, R .
ANNALS OF ONCOLOGY, 2005, 16 (02) :253-258
[3]   Doxorubicin-induced cardiomyopathy [J].
Singal, PK ;
Iliskovic, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (13) :900-905
[4]   Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer [J].
Venturini, M ;
Michelotti, A ;
DelMastro, L ;
Gallo, L ;
Camino, F ;
Garrone, O ;
Tibaldi, C ;
Molea, N ;
Bellina, RC ;
Pronzato, P ;
Cyrus, P ;
Vinke, J ;
Testore, F ;
Guelfi, M ;
Lionetto, R ;
Bruzzi, P ;
Conte, PF ;
Rosso, R .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) :3112-3120
[5]   Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation [J].
Zambetti, M ;
Moliterni, A ;
Materazzo, C ;
Stefanelli, M ;
Cipriani, S ;
Valagussa, P ;
Bonadonna, G ;
Gianni, L .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :37-43
1